March 25 (Reuters) - Genovis AB GENOb.ST:
ENTERS NON-EXCLUSIVE LICENSE AGREEMENT FOR ENDOS2 ENZYME TECHNOLOGY FOR ANTIBODY-DRUG CONJUGATE (ADC) DEVELOPMENT AND COMMERCIALIZATION
LICENSE ENABLES RESEARCH, DEVELOPMENT, MANUFACTURE, AND COMMERCIALIZATION OF ADC PRODUCTS ACROSS ALL INDICATIONS
Further company coverage: [GENOb.ST]